The cellular pharmacology of methotrexate
- 1 January 1985
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 28 (1) , 77-102
- https://doi.org/10.1016/0163-7258(85)90083-x
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Effects of metabolic deprivation on methotrexate transport in L1210 leukemia cells: Further evidence for separate influx and efflux systems with different energetic requirementsThe Journal of Membrane Biology, 1984
- Further studies on the charge-related alterations of methotrexate transport in Ehrlich ascites tumor cells by ionic liposomes: Correlation with liposome-cell associationThe Journal of Membrane Biology, 1982
- Further studies of stereospecificity at carbon 6 for membrane transport of tetrahydrofolatesBiochemical Pharmacology, 1982
- Methotrexate-resistant Chinese hamster ovary cells contain a dihydrofolate reductase with an altered affinity for methotrexateBiochemistry, 1980
- 2,4-Diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline (TMQ), a potent non-classical folate antagonist inhibitor—IBiochemical Pharmacology, 1979
- Antifolate transport in L1210 leukemia cells. Kinetic evidence for the non-identity of carriers for influx and effluxBiochimica et Biophysica Acta (BBA) - Biomembranes, 1976
- New Approaches to Cancer Chemotherapy with MethotrexateNew England Journal of Medicine, 1975
- The mechanism of folate transport in rabbit reticulocytesJournal of Clinical Investigation, 1972
- NEW APPROACHES TO CHEMOTHERAPY WITH FOLATE ANTAGONISTS: USE OF LEUCOVORIN “RESCUE” AND ENZYMIC FOLATE DEPLETION*Annals of the New York Academy of Sciences, 1971
- Increased levels of folic acid reductase as a mechanism of resistance to amethopterin in leukemic cellsBiochemical Pharmacology, 1961